Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine

Go back to Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $4.35 
Open $0.38    52 Week Low $0.44 
Day High $0.39    P/E N/A 
Day Low $0.37    EPS $-0.81 
Volume 47,028